乳腺MRI图像纹理分析在乳腺癌中的研究进展

doi:10.11904/j.issn.1002-3070.2022.05.015

摘要/Abstract

摘要： 乳腺癌具有高度异质性,其异质性是造成患者误诊率较高、治疗反应较差及预后不理想等方面的主要原因。纹理分析通过提取不同序列图像纹理特征来评价瘤体及其周围基质的异质性,并将结果与临床、组织病理学和基因组信息相结合,让其能无创地对乳腺病变进行前瞻性评估和预测。随着医学成像领域的高速发展,纹理分析技术不断进步,能够更准确地判断乳腺病变的性质及预后,为临床精准治疗提供更多的信息。本文就纹理分析在鉴别乳腺肿瘤良恶性、预测乳腺癌分子亚型及评估乳腺肿瘤新辅助化疗疗效等方面展开综述。

关键词: 磁共振成像, 纹理分析, 乳腺癌, 新辅助化疗, 分子亚型

Abstract: Breast cancer is highly heterogeneous,and its heterogeneity is the main reason for high misdiagnosis rate,poor treatment response and poor prognosis.Texture analysis evaluates the heterogeneity of tumor body and its surrounding stroma by extracting texture features of different sequence images,and combines the results with clinical,histopathological,and genomic information,so that it can make a noninvasive prospective evaluation and prediction of breast lesions.With the rapid development of medical imaging,texture analysis technology continues to improve,which can more accurately judge the nature and prognosis of breast lesions,and provide more information for clinical precise treatment.This review focuses on the application of texture analysis in differentiating benign and malignant breast tumors,predicting molecular subtypes of breast cancer,and evaluating the efficacy of neoadjuvant chemotherapy for breast cancer.

Key words: Magnetic resonance imaging, Texture analysis, Breast cancer, Neoadjuvant chemotherapy, Molecular subtype

中图分类号:

R737.9

康子曼, 杨聃琳, 孙建男. 乳腺MRI图像纹理分析在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 472-476.

KANG Ziman, YANG Danlin, SUN Jiannan. Progress of breast MRI image texture analysis in breast cancer[J]. Journal of Practical Oncology, 2022, 36(5): 472-476.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.05.015

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I5/472

参考文献

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 Lambin P,Rios-Velazquez E,Leijenaar R,et al.Radiomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.
3 Soni N,Priya S,Bathla G.Texture analysis in cerebral gliomas:a review of the literature[J].AJNR Am J Neuroradiol,2019,40(6):928-934.
4 Brown RA,Frayne R.A comparison of texture quantification techniques based on the Fourier and S transforms[J].Med Phys,2008,35(11):4998-5008.
5 Dettori L,Semler L.A comparison of wavelet,ridgelet,and curvelet-based texture classification algorithms in computed tomography[J].Comput Biol Med,2007,37(4):486-498.
6 Pfaehler E,Zhovannik I,Wei L,et al.A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features[J].Phys Imaging Radiat Oncol,2021,20:69-75.
7 Yamashita R,Perrin T,Chakraborty J,et al.Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation[J].Eur Radiol,2020,30(1):195-205.
8 Holli K,Lääperi AL,Harrison L,et al.Characterization of breast cancer types by texture analysis of magnetic resonance images[J].Acad Radiol,2010,17(2):135-141.
9 Karahaliou A,Vassiou K,Arikidis NS,et al.Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis[J].Br J Radiol,2010,83(988):296-309.
10 Parekh VS,Jacobs MA.Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI[J].NPJ Breast Cancer,2017,3:43.
11 Wang BT,Fan WP,Xu H,et al.Value of magnetic resonance imaging texture analysis in the differential diagnosis of benign and malignant breast tumors[J].Chin Med Sci J,2019,34(1):33-37.
12 Jiang X,Xie F,Liu L,et al.Discrimination of malignant and benign breast masses using automatic segmentation and features extracted from dynamic contrast-enhanced and diffusion-weighted MRI[J].Oncol Lett,2018,16(2):1521-1528.
13 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J].中国癌症杂志,2021,31(10):954-1040.
14 Li H,Zhu Y,Burnside ES,et al.Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set[J].NPJ Breast Cancer,2016,2:16012.
15 Wang H,Hu Y,Li H,et al.Preliminary study on identification of estrogen receptor-positive breast cancer subtypes based on dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)texture analysis[J].Gland Surg,2020,9(3):622-628.
16 Xu A,Chu X,Zhang S,et al.Prediction breast molecular typing of invasive ductal carcinoma based on dynamic contrast enhancement magnetic resonance imaging radiomics characteristics:a feasibility study[J].Front Oncol,2022,12:799232.
17 王卉,胡云婷,谢元亮,等.基于DCE-MRI纹理分析鉴别雌激素受体阳性乳腺癌亚型的初步研究[J].实用医学杂志,2020,36(2):244-248.
18 Just N.Improving tumour heterogeneity MRI assessment with histograms[J].Br J Cancer,2014,111(12):2205-2213.
19 Foroutan P,Kreahling JM,Morse DL,et al.Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy[J].PLoS One,2013,8(12):e82875.
20 Holli-Helenius K,Salminen A,Rinta-Kiikka I,et al.MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes-a feasibility study[J].BMC Med Imaging,2017,17(1):69.
21 王春华,罗红兵,刘圆圆,等.基于药代动力学动态增强磁共振的影像组学特征对三阴型乳腺癌诊断价值的研究[J].磁共振成像,2021,12(2):29-33.
22 Wang J,Kato F,Oyama-Manabe N,et al.Identifying triple-negative breast cancer using background parenchymal enhancement heterogeneity on dynamic contrast-enhanced MRI:a pilot radiomics study[J].PLoS One,2015,10(11):e0143308.
23 Zhang S,Wang X,Yang Z,et al.Intra-and peritumoral radiomics model based on early DCE-MRI for preoperative prediction of molecular subtypes in invasive ductal breast carcinoma:a multitask machine learning study[J].Front Oncol,2022,12:905551.
24 何洋,赵伟鹏,佟仲生.新辅助化疗对乳腺癌ER PR HER2及Ki-67表达影响的研究进展[J].中国肿瘤临床,2020,47(22):1185-1188.
25 Vaidya JS,Massarut S,Vaidya HJ,et al.Rethinking neoadjuvant chemotherapy for breast cancer[J].BMJ,2018,360:5913.
26 Caudle AS,Gonzalez-Angulo AM,Hunt KK,et al.Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer[J].J Clin Oncol,2010,28:1821-1828.
27 路红,季宇,张迎等.多参数磁共振成像在乳腺癌新辅助化疗中的应用研究进展[J].中国肿瘤临床,2021,48(20):1056-1060.
28 Parikh J,Selmi M,Charles-Edwards G,et al.Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy[J].Radiology,2014,272(1):100-112.
29 曹崑,刘慧,赵博,等.早期增强MRI纹理特征分析对乳腺癌新辅助化疗后病理完全缓解的判断能力[J].中华放射学杂志,2018,52(7):523-527.
30 姚纯,杨志企,杨佳达,等.基于动态增强MRI影像组学评分和激素受体的列线图预测乳腺癌新辅助化疗不敏感的价值[J].国际医学放射学杂志,2022,45(2):130-134.
31 Xiong Q,Zhou X,Liu Z,et al.Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy[J].Clin Transl Oncol,2020,22(1):50-59.
32 Pesapane F,Rotili A,Botta F,et al.Radiomics of MRI for the prediction of the pathological response to neoadjuvant chemotherapy in breast cancer patients:a single referral centre analysis[J].Cancers(Basel),2021,13(17):4271.
33 Braman NM,Etesami M,Prasanna P,et al.Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI[J].Breast Cancer Res,2017,19(1):57.
34 Braman N,Prasanna P,Whitney J,et al.Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2(ERBB2)-positive breast cancer[J].JAMA Netw Open,2019,2(4):e192561.

[1]	闵智乾, 靳荣辉, 陈丽宏, 雷晓燕, 张鑫, 张彬, 于娇, 蔺莉莉, 陈小龙. 多模态MRI评价ⅠB1-ⅡA2期宫颈癌宫旁浸润的应用研究[J]. 实用肿瘤学杂志, 2022, 36(5): 424-428.
[2]	王星涵, 吕雅蕾. 曲妥珠单抗耐药机制及HER2阳性乳腺癌耐药后的治疗策略[J]. 实用肿瘤学杂志, 2022, 36(5): 445-451.
[3]	李智慧, 李志高. 恩美曲妥珠单抗T-DM1在HER2阳性乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 477-482.
[4]	陈嘉一, 白彦灵. 乳腺癌患者体重指数及体位固定方式对保乳术后调强放射治疗摆位误差的影响[J]. 实用肿瘤学杂志, 2022, 36(4): 327-331.
[5]	赵丹妮, 闫石, 蔡莉. 乳腺癌随访和药物副作用管理策略的研究进展[J]. 实用肿瘤学杂志, 2022, 36(4): 369-373.
[6]	宗禹萱, 庞达. 热休克蛋白90在乳腺癌发生发展及治疗中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(4): 381-385.
[7]	杨子涵, 许守平, 庞达. 乳腺癌发生腋窝外三角组织转移特点与影响因素分析[J]. 实用肿瘤学杂志, 2022, 36(3): 226-232.
[8]	何伟丹, 李志高. FSIP1促进乳腺癌细胞迁移和侵袭并导致患者不良预后[J]. 实用肿瘤学杂志, 2022, 36(3): 233-238.
[9]	刘欣欣, 姚欣卉, 孙跃峰, 缪美琪, 陈晶. 乳腺癌微环境中趋化因子CCL20作用的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 250-254.
[10]	杨姝娅, 刘文慧, 骆耐香. UCA1在乳腺癌中的研究现状和应用展望[J]. 实用肿瘤学杂志, 2022, 36(3): 263-267.
[11]	刘婉莹, 庞达. 乳腺浸润性微乳头状癌转移机制的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 268-272.
[12]	孙元元, 张苧之, 曹孟儒. 乳腺癌肺转移机制及治疗进展[J]. 实用肿瘤学杂志, 2022, 36(2): 173-177.
[13]	侯建勋, 王洪斌. 外泌体对乳腺癌诊疗一体化影响的研究进展[J]. 实用肿瘤学杂志, 2022, 36(2): 178-182.
[14]	陈赫, 王秋程, 程文. 自动乳腺超声诊断系统在乳腺癌方面的应用进展[J]. 实用肿瘤学杂志, 2022, 36(2): 193-196.
[15]	李伟华, 张广凤, 马骊骊, 何品, 王雯, 李顶夫. 基于TCGA数据库代谢相关基因构建乳腺癌预后模型[J]. 实用肿瘤学杂志, 2022, 36(1): 37-43.